OTSUKA HOLDINGS CO., LTD Overview
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: Tokyo, Japan
Founded: 2008
Workforce: ~47,000
Company Working: Otsuka Holdings Co., Ltd develops and markets pharmaceutical and nutraceutical products worldwide. The company operates through four segments, namely, pharmaceuticals, nutraceuticals, consumer products, and others. It offers dietary supplements under its nutraceuticals business segment. The company is present in all established and emerging markets and has a direct presence via subsidiaries in more than 28 countries. It has 177 manufacturing units and 45 research and development centers across the globe.
Strategy
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Otsuka Holdings Co., Ltd is engaged in strategic acquisitions to enhance its technological capabilities and expand its product line to provide innovative products in the market. It has more than 162 subsidiaries and 26 affiliates in major markets, offering a competitive advantage over other market players. The company is also focused on gaining FDA approvals for the launch of new products. To grow in the global dietary supplements market, the company lays emphasis on mergers and acquisitions. For instance, Otsuka Holdings Co., Ltd acquired FoodState Inc., a manufacturer of natural whole-food supplements, with an aim to enter the natural food supplements market.
